Skip to content

Negative Pressure Ventilation in Paediatric Patients During Weaning

Negative Pressure Ventilation in Critically Ill Paediatric Patients During Weaning: Prospective Randomized Interventional Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05035290
Acronym
NEGWEAN
Enrollment
200
Registered
2021-09-05
Start date
2022-02-01
Completion date
2023-12-31
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weaning Failure

Keywords

Weaning, Weaning failure, Negative pressure ventilation, Cuirass, Paediatric patient, Critical care

Brief summary

Negative pressure ventilation (NPV) represent a unique form of noninvasive ventilation using negative pressure by specialized cuirass, that evolve negative pressure on the front size of chest and partially abdomen and facilitate the spontaneous breathing. The benefit of NPV beside noninvasive application, is the supreme tolerance of the patient (compared to other forms of noninvasive ventilation - mask, helmet), without the negative impact on enteral feeding tolerance and with the possibility of active physiotherapy. NPV could be even combined with oxygentherapy or noninvasive positive pressure ventilation. NPV in paediatric patients after extubation could be associated with reduced incidence of weaning failure.

Detailed description

After ethics committee approval and informed consent from legal guardians and fulfilling inclusion criteria, critically ill paediatric patients scheduled for weaning will be randomized (in 1:1 allocation) to NPV (interventional group) or standard approach (without NPV) after extubation. NPV in paediatric patients after extubation could be associated with reduced incidence of weaning failure. The initial setting on NPV will be: negative pressure set to -10cmH2O and will proceed for minimal time of 60 minutes after extubation (will proceed longer in case of good tolerance). In case of hypoxaemia, additional oxygentherapy will be administered according to the patients condition Primary outcome will be defined as postextubation failure incidence at 60 minutes after extubation (defined as need of noninvasive positive pressure ventilation, intubation, or high-flow oxygen therapy) and the overall incidence of weaning failure during initial 24 hour after extubation. The secondary outcome will be the dynamics of blood gases (arterial or capillary blood sample) during initial 60 minutes after extubation (1. extubation, 2. 60 minutes after extubation) and the need of and amount of artificial oxygentherapy (litres of oxygen per minute, pulse oximetry). Another outcome will be the overall cuirass tolerance after 60 minutes and after 24 hours defined by incidence of skin lesions.

Interventions

Negative pressure ventilation - cuirass will be applied on the patient´s ches and abdomen immediately after extubation

Sponsors

Masaryk University
CollaboratorOTHER
Brno University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Critically ill paediatric patients scheduled for weaning from mechanical ventilation will be randomized to interventional group (negative pressure ventilation) and control group (standard approach)

Eligibility

Sex/Gender
ALL
Age
1 Months to 19 Years
Healthy volunteers
No

Inclusion criteria

* invasive mechanical ventilation * informed consent * scheduled for weaning

Exclusion criteria

* neuromuscular disorder * mechanical ventilation at home (chronic use) * less than 24 hours after abdominal or thoracic surgery * technical problems with the cuirass - chest drain

Design outcomes

Primary

MeasureTime frameDescription
Early weaning failurein 60 minutes after extubationIncidence of early weaning failure - intubation, noninvasive positive pressure ventilation, high flow oxygen therapy
Overall weaning failureduring 24 hours after extubationIncidence of weaning failure - intubation, noninvasive positive pressure ventilation, high flow oxygen therapy

Secondary

MeasureTime frameDescription
Blood gases trendsduring initial 60 minutes after extubationTrends of blood gases (CO2 and O2) in arterial or capillary blood samples drown at the extubation and in 60 minutes after extubation
Pulse oximetry trendduring initial 60 minutes after extubationTrends of pulse oximetry during initial 60 minutes after extubation
Early cuirass toleranceduring initial 60 minutes after extubationIncidence of the need for cuirass removal during initial 60 minutes
Overall cuirass toleranceduring 24 hours after extubationDefined by incidence of new skin lesions after cuirass application

Countries

Czechia

Contacts

Primary ContactJozef Klučka, assoc.prof.MD., Ph.D.
klucka.jozef@fnbrno.cz532234696
Backup ContactMilan Kratochvíl, MD. EDIC
kratochvil.milan@fnbrno.cz532234696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026